[Journal of Translational Medicine] The small molecules A83-01, pomalidomide, and UM171 were used for the ex vivo expansion, lentiviral transduction, and long-term cultivation of umbilical cord blood-derived hematopoietic stem and progenitor cells.
[Stem Cell Reports] The authors identified DHX9 as a critical regulator of HSC maintenance. Dhx9 deletion caused bone marrow failure and impaired hematopoietic reconstitution in murine primary and secondary transplantation recipients due to loss of HSCs and defective self-renewal capacity.
[Journal of Investigative Dermatology] Single-cell RNA sequencing and spatial transcriptomics revealed restoration of fibroblast, basal cell, and melanocyte proportions, suppression of myofibroblast differentiation, and upregulation of ECM-related genes.
[American Journal of Pathology] Reseachers profiled temporal dynamics of human stem cell-derived skin organoid vasculogenesis and interrogated organoid responses to inflammatory and traumatic stimuli.
[JCI Insight] Scientists investigated the relevance of plakoglobin phosphorylation at S665 for stabilization of keratinocyte cohesion and further characterized the underlying mechanisms.
[Muscular Dystrophy Canada] Muscular Dystrophy Canada announced the launch of the Neuromuscular Disease Real-World eXperience Registry designed to reshape neuromuscular research, policy, and care.
[Tenaya Therapeutics, Inc.] Tenaya Therapeutics, Inc. announced that the US FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to TN-401, Tenaya’s gene therapy candidate for the treatment of PKP2-associated arrhythmogenic right ventricular cardiomyopathy.
[Science Translational Medicine] Scientists performed single-nucleus RNA sequencing of cardiac tissues from 47 patients with hypertrophic cardiomyopathy and compared them with nonfailing donor and dilated cardiomyopathy hearts to investigate stage- and genotype-specific disease mechanisms.